Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: This regionally aligned team (Northeast, Southeast, Central, and West) will manage the launch and ongoing lifecycle of Revolution Medicines’ approved therapies using a patient centric model. This role requires a strategic team player with deep expertise in oncology market access, clinical knowledge, and a passion for ensuring no patient is left behind. The Field Reimbursement Director (FRD) serves as key field-based expert in market access and the subject matter expert in navigating the reimbursement and access landscape for healthcare providers, office staff, and other critical stakeholders. This role provides education across the entire access journey, with deep expertise in prior authorization processes, coverage criteria, and payer-specific requirements across commercial, Medicare, and Medicaid plans. This role requires strong business acumen, an understanding of the national payer environment, and the ability to build trusted relationships with provider offices, HUB services, Nurse Case Managers, specialty pharmacies, and internal cross-functional partners. The FRD ensures a positive customer experience by delivering clear guidance, resolving issues efficiently, and supporting timely and appropriate patient access to therapy.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director